Medication info
Pastel Tablet 20 mg (Famotidine)

Pastel Tablet 20 mg (Famotidine)

Prescription medicationTabletOral
Ingredient · strength
Famotidine›20mg / 1 tablet
Manufacturer / importer
Samchundang Pharm. Co., Ltd.
Appearance
White round film-coated tablets
Packaging
30 tablets/bottle, 500 tablets/bottle
Approval status
Active

MFDS item code 202000476 · Approved 2020.01.29 · Insurance code 651205380

Summary

Main use
Treatment of acid-related disorders (e.g., ulcers and gastroesophageal reflux disease) and upper gastrointestinal bleeding; improvement of gastritis lesions
Who takes it
Adults
Adult dose
1. Gastric and duodenal ulcers, anastomotic ulcers, upper gastrointestinal bleeding (due to peptic ulcers, acute stress ulcers, or bleeding ulcers), reflux esophagitis, and Zollinger-Ellison syndrome: Adults Administer famotidine orally at a dose of 20mg twice daily (after breakfast and dinner, or at bedtime), or 40mg once daily (at bedtime). For upper gastrointestinal bleeding, treatment is usually initiated with an injectable formulation; switch to oral administration once oral intake is possible. 2. Improvement of gastric mucosal lesions (erosions, bleeding, redness, and edema) associated with the following conditions: acute gastritis and acute exacerbation of chronic gastritis Adults: Administer famotidine orally at a dose of 10mg twice daily (after breakfast and dinner, or at bedtime), or 20mg once daily (at bedtime). Adjust the dose as appropriate according to age and symptoms.

Ingredients

Manufacturer
Samchundang Pharm. Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (e.g., ulcers and gastroesophageal reflux disease) and upper gastrointestinal bleeding; improvement of gastritis lesions

  • Gastric and duodenal ulcers
  • anastomotic ulcers
  • upper gastrointestinal bleeding
  • acute stress ulcer
  • hemorrhagic gastritis
  • gastroesophageal reflux disease
  • Zollinger-Ellison syndrome
  • gastric mucosal lesions
  • erosion
  • bleeding
  • redness
  • swelling
View approved original text

This medication is used in the treatment of peptic ulcers, including gastric and duodenal ulcers, anastomotic ulcers, and upper gastrointestinal bleeding. It is also effective for gastroesophageal reflux disease and Zollinger-Ellison syndrome. It helps to improve lesions such as erosion, bleeding, redness, and swelling of the gastric mucosa during acute exacerbations of acute and chronic gastritis. This medication contributes to relieving symptoms by protecting the gastric mucosa and reducing gastric acid secretion. It is used to restore the patient's gastrointestinal health and improve symptoms.

How to take

Adult dose

1. Gastric and duodenal ulcers, anastomotic ulcers, upper gastrointestinal bleeding (due to peptic ulcers, acute stress ulcers, or bleeding ulcers), reflux esophagitis, and Zollinger-Ellison syndrome: Adults Administer famotidine orally at a dose of 20mg twice daily (after breakfast and dinner, or at bedtime), or 40mg once daily (at bedtime). For upper gastrointestinal bleeding, treatment is usually initiated with an injectable formulation; switch to oral administration once oral intake is possible. 2. Improvement of gastric mucosal lesions (erosions, bleeding, redness, and edema) associated with the following conditions: acute gastritis and acute exacerbation of chronic gastritis Adults: Administer famotidine orally at a dose of 10mg twice daily (after breakfast and dinner, or at bedtime), or 20mg once daily (at bedtime). Adjust the dose as appropriate according to age and symptoms.

Precautions

This drug should not be used by patients who are allergic to certain ingredients or have hereditary lactose metabolism disorders. Patients with renal or liver dysfunction, those with heart disease, and the elderly should use this drug with caution. Serious side effects such as allergic reactions, blood anomalies, severe skin conditions, liver dysfunction, muscle damage, cardiac rhythm abnormalities, changes in consciousness, and kidney issues may occur during use, necessitating careful observation. This medication dissolves in the mouth but is not absorbed through the mucosa, so it must be swallowed with water. Patients undergoing hemodialysis should be cautious, as the effectiveness of this medication may decrease when used with phosphate binders. Using this medication together with other specific drugs may reduce the effectiveness of this or other medications, so consulting a doctor or pharmacist is essential. Elderly patients may have decreased renal function, so the dosage should be adjusted or the dosing interval extended. Women who are pregnant or may become pregnant should only use this medication carefully when needed and should consider stopping breastfeeding if using it while nursing. Safety in children has not been fully established, so use should be avoided.

Side effects

  • Shock
  • hypersensitivity
  • anaphylaxis
  • dyspnea
  • generalized flush
  • angioedema
  • facial edema
  • pharyngeal edema
  • urticaria
  • pancytopenia
Show 75 more
  • agranulocytosis
  • aplastic anemia
  • hemolytic anemia
  • thrombocytopenia
  • generalized malaise
  • weakness
  • subcutaneous hemorrhage
  • mucosal hemorrhage
  • fever
  • Stevens-Johnson syndrome
  • Lyell's syndrome
  • liver function impairment
  • jaundice
  • rhabdomyolysis
  • hyperkalemia
  • myoglobinuria
  • elevation of serum muscle enzymes
  • myalgia
  • QT prolongation
  • ventricular tachycardia
  • Torsades de Pointes
  • ventricular fibrillation
  • disturbance of consciousness
  • convulsion
  • generalized convulsion
  • tonic seizure
  • clonic seizure
  • interstitial nephritis
  • acute renal failure
  • rash
  • urticaria
  • leukopenia
  • eosinophilia
  • constipation
  • diarrhea
  • clay-colored stools
  • thirst
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • stomatitis
  • hypertension
  • facial flush
  • tinnitus
  • bradycardia
  • tachycardia
  • atrioventricular block
  • bronchospasm
  • elevated AST
  • elevated ALT
  • elevated ALP
  • elevated total bilirubin
  • elevated LDH
  • hepatitis
  • generalized malaise
  • fatigue
  • headache
  • drowsiness
  • insomnia
  • hallucinations
  • anxiety
  • agitation
  • decreased libido
  • paresthesia
  • feeling of heaviness in the head
  • reversible confusional state
  • depression
  • dizziness
  • irregular menstruation
  • gynecomastia
  • arthralgia
  • elevated CK
  • dysgeusia
  • muscle cramps

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air or moisture ingress. It is best to maintain the storage temperature between 1°C and 30°C.

Appearance and packaging

Appearance

White round film-coated tablets

Package unit

30 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.